In a significant milestone for the decentralized finance (DeFi) ecosystem, Bitoro, a perpetual futures trading network, has launched on the Injective protocol, a decentralized blockchain focused on Web3 financial solutions. This deployment marks a crucial step in Bitoro's mission to expand its decentralized trading solutions, offering users instant, low-cost trading, and advanced features like institutional gateways and on-chain perpetuals for real-world assets (RWAs).

The partnership with Injective enables Bitoro to leverage the protocol's robust infrastructure, enhancing its platform's capabilities and broadening its reach. Injective's co-founder and CEO, Eric Chen, highlights the benefits of this collaboration, stating that Bitoro will benefit from Injective's on-chain order book and plug-and-play modules.

Perpetual futures contracts, a key feature of Bitoro's platform, differ from traditional futures contracts in that they have no expiration dates and are settled in cash. These contracts play a crucial role in maintaining market stability and trading at prices similar to the current market rate, achieved through the funding rate mechanism.

The launch on Injective follows Bitoro's deployment on five other ecosystems, including Avalanche, Base, Arbitrum, Optimism, and Mantle. This expansion demonstrates Bitoro's commitment to providing decentralized trading solutions, promoting market stability, and fostering growth in the DeFi ecosystem.

In related news, Taiwan has established the Virtual Asset Service Provider (VASP) Association, a self-regulatory body aimed at promoting rigorous and fair regulations for the digital asset industry. The association comprises 24 crypto firms, including XREX and BitoPro, and will work closely with the government and law enforcement agencies to combat fraud and criminal activities.